Tue, Aug 06, 2024
Lupin Q1 FY25 Results Preview: Mumbai-headquartered drug maker Lupin is estimated to register a 30 per cent year-on-year jump in its consolidated net profit for the April-June period. Read on to know what else you can expect in the pharmaceutical company's upcoming earnings report.
More >
Mon, Jul 29, 2024
Strides Pharma Science's revenue stood at Rs 1,087 crore in the period under review compared to Rs 932 crore in the year-ago quarter, the pharma company said.
Thu, Jul 18, 2024
Mumbai-based Lupin has signed a license and supply agreement with Huons for the registration and marketing of Cyclosporine Ophthalmic Nanoemulsion (0.4mL single-use vial) in Mexico.
Wed, Mar 08, 2023
Cipla shares succumbed to selling pressure on Wednesday, after four brokerages reduced their target prices for the drug maker in two days. Analysts say concerns persist among investors about the pharma company's key manufacturing facilities.
Tue, Feb 28, 2023
Nifty Pharma and BSE Healthcare indices were trading below the flat line as most drug makers like Cipla, Biocon, Dr Reddy’s, and Alkem among others were a mixed bag
The National Pharmaceutical Pricing Authority (NPPA) on Monday fixed the prices under the Drugs (Price Control) Order 2013 based on the decision of the 109th authority meeting held on February 21 this year, according to a PTI report.
Mon, Feb 20, 2023
Cipla share price today BSE, NSE: Cipla shares suffered steep losses on Monday after the drug maker said US health regulator had issued eight observations on its manufacturing facility in Pitampur, Madhya Pradesh. The Cipla stock fell by as much as Rs 69.6 or 6.8 per cent to Rs 956.2 apiece on BSE.
Tue, Jan 31, 2023
Sun Pharma Q3 Results: The pharmaceutical major reported a 5.2 per cent year-on-year increase in net profit to Rs 2,166 crore for the quarter ended December 2022.
Mon, Jan 30, 2023
Jefferies, JP Morgan and Morgan Stanley have maintained 'buy' or overweight ratings on Bajaj Finance. CLSA has upgraded the NBFC stock to 'reduce' from 'sell'.
Fri, Jan 27, 2023
Which shares are today's Stock of the day? What to do in Dixon tech today? How are the results of Tata Motors, Dr Reddy's and Cipla? Are the bad times over for pharma stocks? Know full analysis of December quarter results from Anil Singhvi.
Wed, Jan 25, 2023
Cipla Q3 Results: The drug maker reported a 9.9 per cent year-on-year increase in net profit to Rs 801 crore for the October-December period and revenue growth of six per cent to Rs 5,810.1 crore — both missing analysts' estimates. Cipla shares extended their intraday losses after the earnings announcement.
Wed, Jan 11, 2023
Pharma stocks have been among the worst hit spaces on Dalal Street in the past few months.
Jefferies and HSBC have recommended, Cipla, Sun Pharma, Divi's Laboratories, Biocon, Lupin and others
Thu, Dec 22, 2022
Stock Market Today Updates: Global stock markets rose on Wednesday, as the US consumer confidence rebounded in December, and the dollar regained stability after the Bank of Japan rocked markets with a surprise decision to loosen its grip on government bond yields.
Wed, Dec 21, 2022
Stocks of healthcare and pharma majors like Divi’s Laboratories, Apollo Hospital and others were on a roll during Wednesday’s session as fear related to fresh wave of coronavirus cases returned.
Tue, Nov 01, 2022
How are Piramal Pharma valuations now after Demerger? What is Piramal Pharma's business, how are the financials? Why focus on Pharma Stocks? What to do in Piramal Pharma now? Watch this special research on the valuations of Piramal Pharma.
Thu, Sep 29, 2022
The Nifty Pharma is one of the top sectoral gainers as compared to a 0.16 per cent fall in the Nifty, it jumped by 3.5 per cent this week against to 1.5 per cent fall in the benchmark index.
Thu, Mar 31, 2022
The National Pharma Pricing Authority (NPPA) has approved 10.8% hike in over 800 essential drugs starting April 1,2022. This is the biggest hike by NPPA in the last 10 years.
Thu, Dec 30, 2021
Healthcare and pharmaceuticals companies were in focus on Wednesday even as the stock markets ended negatively.
Thu, Jul 02, 2020
Zee Business Managing Editor Anil Singhvi said that he is not over bullish on pharma stocks for the next 3-4 months. If the markets have discounted the impact of coronavirus, they have also discounted the news of development of the coronavirus vaccine, Singhvi opines
Tue, Jan 08, 2019
In this segment of Zee Business catch all the updates related to how the market performed today. Watch the video to know more.
Tue, Dec 11, 2018
Over the last few elections, markets have performed well, and today too, after quite a horrific fall, they returned to green. If you have invested in these sectors then you will likely gain a hefty amount today.
Fri, Feb 23, 2018
The benchmark indices kicked off the March series on a higher note with the Nifty50 reclaiming its crucial 10,400-mark, tracking positive trend seen in Asian markets. However, the broader momentum remained tepid.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
